Tolerance induction and reversal of diabetes in mice transplanted with human embryonic stem cell-derived pancreatic endoderm.

[1]  D. Melton,et al.  Generation of Functional Human Pancreatic β Cells In Vitro , 2014, Cell.

[2]  James D. Johnson,et al.  Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells , 2014, Nature Biotechnology.

[3]  H. Spits,et al.  Human innate lymphoid cells. , 2014, Blood.

[4]  C. Ricordi,et al.  Long‐term Outcomes after Islet Transplantation , 2014 .

[5]  A. Terzic,et al.  Concise Review: Pluripotent Stem Cell‐Based Regenerative Applications for Failing β‐Cell Function , 2014, Stem cells translational medicine.

[6]  A. Goldrath,et al.  An effective approach to prevent immune rejection of human ESC-derived allografts. , 2014, Cell stem cell.

[7]  K. Ljung,et al.  Costimulation Blockade Induces Foxp3+ Regulatory T Cells to Human Embryonic Stem Cells , 2013, BioResearch open access.

[8]  J. Odegaard,et al.  Costimulation‐adhesion blockade is superior to Cyclosporine A and prednisone immunosuppressive therapy for preventing rejection of differentiated human embryonic stem cells following transplantation , 2013, Stem cells.

[9]  K. Wood,et al.  Ex Vivo Expanded Human Regulatory T Cells Can Prolong Survival of a Human Islet Allograft in a Humanized Mouse Model , 2013, Transplantation.

[10]  Joseph C. Wu,et al.  Immunogenicity of Pluripotent Stem Cells and Their Derivatives , 2013, Circulation research.

[11]  D. Greiner,et al.  Humanized mice for immune system investigation: progress, promise and challenges , 2012, Nature Reviews Immunology.

[12]  G. Warnock,et al.  Maturation of Human Embryonic Stem Cell–Derived Pancreatic Progenitors Into Functional Islets Capable of Treating Pre-existing Diabetes in Mice , 2012, Diabetes.

[13]  S. Anderson,et al.  Islet Cell Transplantation in Type 1 Diabetes: An Analysis of Efficacy Outcomes and Considerations for Trial Designs , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[14]  Nicole A. Turgeon,et al.  Improvement in Outcomes of Clinical Islet Transplantation: 1999–2010 , 2012, Diabetes Care.

[15]  B. Hering,et al.  Potent Induction Immunotherapy Promotes Long‐Term Insulin Independence After Islet Transplantation in Type 1 Diabetes , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[16]  M. Hebrok.  Generating β cells from stem cells-the story so far. , 2012, Cold Spring Harbor perspectives in medicine.

[17]  Allan J. Robins,et al.  A Scalable System for Production of Functional Pancreatic Progenitors from Human Embryonic Stem Cells , 2012, PloS one.

[18]  J. Bluestone,et al.  CD4(+)Foxp3(+) regulatory T cell therapy in transplantation. , 2012, Journal of molecular cell biology.

[19]  I. Shimomura,et al.  Human Leukocyte Antigen I Knockdown Human Embryonic Stem Cells Induce Host Ignorance and Achieve Prolonged Xenogeneic Survival , 2011, Circulation.

[20]  P. Tsao,et al.  Immunobiology of naïve and genetically modified HLA-class-I-knockdown human embryonic stem cells , 2011, Journal of Cell Science.

[21]  G. Korbutt,et al.  CD40‐Specific Costimulation Blockade Enhances Neonatal Porcine Islet Survival in Nonhuman Primates , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[22]  Mark M. Davis,et al.  Short-term immunosuppression promotes engraftment of embryonic and induced pluripotent stem cells. , 2011, Cell stem cell.

[23]  G. Szot,et al.  Islet Transplantation in Type 1 Diabetic Patients Using Calcineurin Inhibitor-Free Immunosuppressive Protocols Based on T-Cell Adhesion or Costimulation Blockade , 2010, Transplantation.

[24]  Kathy O. Lui,et al.  A Role for Regulatory T Cells in Acceptance of ESC‐Derived Tissues Transplanted Across an Major Histocompatibility Complex Barrier , 2010, Stem cells.

[25]  Guibin Chen,et al.  Major Histocompatibility Complex‐I Expression on Embryonic Stem Cell‐Derived Vascular Progenitor Cells Is Critical for Syngeneic Transplant Survival , 2010, Stem cells.

[26]  U. Masharani,et al.  Islet Transplantation in Type 1 Diabetics Using an Immunosuppressive Protocol Based on the Anti‐LFA‐1 Antibody Efalizumab , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[27]  R. Jaenisch,et al.  Pluripotent stem cells are highly susceptible targets for syngeneic, allogeneic, and xenogeneic natural killer cells , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[28]  Jeffrey A. Bluestone,et al.  Genetics, pathogenesis and clinical interventions in type 1 diabetes , 2010, Nature.

[29]  H. Reijonen,et al.  Recurrence of Type 1 Diabetes After Simultaneous Pancreas-Kidney Transplantation, Despite Immunosuppression, Is Associated With Autoantibodies and Pathogenic Autoreactive CD4 T-Cells , 2010, Diabetes.

[30]  G. Korbutt,et al.  Short-Term Administrations of a Combination of Anti–LFA-1 and Anti-CD154 Monoclonal Antibodies Induce Tolerance to Neonatal Porcine Islet Xenografts in Mice , 2010, Diabetes.

[31]  A. Rigby,et al.  The Diabetes Control and Complications Trial: the gift that keeps giving , 2009, Nature Reviews Endocrinology.

[32]  Robin Goland,et al.  Generation of pluripotent stem cells from patients with type 1 diabetes , 2009, Proceedings of the National Academy of Sciences.

[33]  Dennis van Hoof,et al.  Derivation of insulin-producing cells from human embryonic stem cells. , 2009, Stem cell research.

[34]  D. Busch,et al.  Role of Natural‐Killer Group 2 Member D Ligands and Intercellular Adhesion Molecule 1 in Natural Killer Cell‐Mediated Lysis of Murine Embryonic Stem Cells and Embryonic Stem Cell‐Derived Cardiomyocytes , 2009, Stem cells.

[35]  G. Korbutt,et al.  In vivo characterization of transplanted human embryonic stem cell‐derived pancreatic endocrine islet cells , 2008, Cell proliferation.

[36]  Rutger-Jan Swijnenburg,et al.  Immunosuppressive therapy mitigates immunological rejection of human embryonic stem cell xenografts , 2008, Proceedings of the National Academy of Sciences.

[37]  J. Bluestone,et al.  Control of peripheral T‐cell tolerance and autoimmunity via the CTLA‐4 and PD‐1 pathways , 2008, Immunological reviews.

[38]  G. Dellgren,et al.  Costimulation Blockade Induces Tolerance to HESC Transplanted to the Testis and Induces Regulatory T‐Cells to HESC Transplanted into the Heart , 2008, Stem cells.

[39]  L. Chatenoud.  Chemical immunosuppression in islet transplantation--friend or foe? , 2008, The New England journal of medicine.

[40]  A. Bang,et al.  Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo , 2008, Nature Biotechnology.

[41]  H. Waldmann,et al.  Embryonic stem cell-derived tissues are immunogenic but their inherent immune privilege promotes the induction of tolerance , 2007, Proceedings of the National Academy of Sciences.

[42]  G. Szot,et al.  Transplantation of pancreatic islets into the kidney capsule of diabetic mice. , 2007, Journal of visualized experiments : JoVE.

[43]  G. Korbutt,et al.  Generation of Insulin‐Producing Islet‐Like Clusters from Human Embryonic Stem Cells , 2007, Stem cells.

[44]  J. Odorico,et al.  Undifferentiated murine embryonic stem cells cannot induce portal tolerance but may possess immune privilege secondary to reduced major histocompatibility complex antigen expression. , 2006, Stem cells and development.

[45]  E. Kroon,et al.  Production of pancreatic hormone–expressing endocrine cells from human embryonic stem cells , 2006, Nature Biotechnology.

[46]  N. Benvenisty,et al.  Human Embryonic Stem Cells and Their Differentiated Derivatives Are Less Susceptible to Immune Rejection Than Adult Cells , 2006, Stem cells.

[47]  E. Kroon,et al.  Efficient differentiation of human embryonic stem cells to definitive endoderm , 2005, Nature Biotechnology.

[48]  N. Kenyon,et al.  Development of a Chimeric Anti-CD40 Monoclonal Antibody That Synergizes with LEA29Y to Prolong Islet Allograft Survival1 , 2005, The Journal of Immunology.

[49]  Li Li,et al.  Human Embryonic Stem Cells Possess Immune‐Privileged Properties , 2004, Stem cells.

[50]  Hyoung-Tae Kim,et al.  Monotherapy with the novel human anti-CD154 monoclonal antibody ABI793 in rhesus monkey renal transplantation model1 , 2004, Transplantation.

[51]  H. Ljunggren,et al.  Co-Stimulatory Molecules in Islet Xenotransplantation: CTLA4Ig Treatment in CD40 Ligand-Deficient Mice , 2002, Cell transplantation.

[52]  B. Thorens,et al.  Differential Sensitivity of GLUT1- and GLUT2-Expressing β Cells to Streptozotocin , 2001 .

[53]  D. Harlan,et al.  Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154. , 1999, Diabetes.

[54]  G. Szot,et al.  Immunosuppressive effects of human CTLA4Ig in a non-human primate model of allogeneic pancreatic islet transplantation. , 1997, Journal of immunology.

[55]  P. Linsley,et al.  Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg. , 1992, Science.

[56]  A. Terzic,et al.  Intrapatient variations in type 1 diabetes-specific iPS cell differentiation into insulin-producing cells. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

[57]  Jan Rodriguez Parkitna,et al.  The FASEB Journal • Research Communication , 2007 .

[58]  B. Thorens,et al.  Differential sensitivity of GLUT1- and GLUT2-expressing beta cells to streptozotocin. , 2001, Biochemical and biophysical research communications.

[59]  J. Bluestone,et al.  Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. , 2001, Annual review of immunology.

[60]  Ames,et al.  Islet Transplantation in Seven Patients with Type 1 Diabetes Mellitus Using a Glucocorticoid-Free Immunosuppressive Regimen , 2000 .